Skip to main content
Cary Fu, MD, Child Neurology, Nashville, TN

CaryFuMD

Child Neurology Nashville, TN

Assistant Professor at Vanderbilt University

Dr. Fu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fu's full profile

Already have an account?

  • Office

    1161 21st Ave S
    # A-0118
    Nashville, TN 37232
    Phone+1 615-936-0060
    Fax+1 615-936-0223

Summary

  • Dr. Cary Fu is a Child Neurologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. He received his medical degree from University of Missouri-Columbia School of Medicine and has been in practice 12 years. He is experienced in pediatric epilepsy, general child neurology and Rett syndrome.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Clinical Neurophysiology, 2008 - 2009
  • University of Alabama Medical Center
    University of Alabama Medical CenterFellowship, Child Neurology, 2005 - 2008
  • University of Arkansas for Medical Sciences (UAMS) College of Medicine
    University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 2002 - 2005
  • University of Missouri-Columbia School of Medicine
    University of Missouri-Columbia School of MedicineClass of 2002

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2009 - 2026
  • AL State Medical License
    AL State Medical License 2005 - 2020
  • American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
  • American Board of Psychiatry and Neurology Clinical Neurophysiology

Publications & Presentations

PubMed

Press Mentions

  • Potential Rett Syndrome Drug Shows Promising Results in Phase 3 Trial
    Potential Rett Syndrome Drug Shows Promising Results in Phase 3 TrialDecember 6th, 2021
  • Rett Syndrome Drug Studied at Vanderbilt Approved for Patients
    Rett Syndrome Drug Studied at Vanderbilt Approved for PatientsJuly 8th, 2023